EFFECT OF ZOLEDRONIC ACID ON OSTEOPOROTIC FRACTURE HEALING.ZOLEDRONIC ACID IS FIRST LINE DRUG FOR TREATMENT OF OSTEOPOROTIC FRACTURES.
Phase 3
- Conditions
- Health Condition 1: S721- Pertrochanteric fracture
- Registration Number
- CTRI/2021/09/036873
- Lead Sponsor
- ANKIT GULIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Intertrochanteric fractures associated with trivial trauma.
Serum calcium more than 8-11 mg per decilitre.
Creatinine clearance more than 30 ml.
Unilateral hip fractures.
Exclusion Criteria
Patient taking oral corticosteroids.
Age less than 50 years.
Patients with active malignancies.
Chronic renal failure.
Secondary osteoporosis.
History of taking zoledronic acid within 1 yr prior to hip fracture
Patients treated with teriparatide.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method